The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...

If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...

A study was conducted to assess the safety and tolerability of the tetravalent live-attenuated dengue vaccine Qdenga®, which received marketing approval in Germany in 2022. The study evaluated vaccine ...

It's a big, germy world out there. If you want to travel with peace of mind, learn the basics of vaccines, illnesses, and ...

Biological scientists have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the permeability of the mosquito midgut for infection.

VI Department of Health reminded residents and visitors to take precautions to protect their health during the 53rd Annual Agriculture and Food Fair weekend. “We are still in flu season, […] ...